Related Experiment Video
Updated: Jun 12, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Current and future therapeutic options for the management of gout
1Universal Clinical Research Center, Inc., Hunt Valley, MD, USA. huntvalley@aol.com
Insights
Gout and hyperuricemia are increasing, causing joint pain and impacting quality of life. This review covers gout pathophysiology, comorbidities, and current and future treatments for hyperuricemia management.
Area of Science:
- Rheumatology
- Nephrology
- Cardiology
Background:
- Rising incidence of gout and hyperuricemia.
- Gout complications include crystal arthropathy, tophi, and renal lithiasis.
- Hyperuricemia is linked to comorbidities like renal impairment and cardiovascular disease.
Purpose of the Study:
- Review the pathophysiology of hyperuricemia and gout.
- Discuss traditional and novel therapeutic options.
- Explore future pharmacologic targets for gout management.
Main Methods:
- Literature review of pathophysiology.
- Analysis of traditional pharmacologic treatments.
- Evaluation of newly available and emerging therapies.
Main Results:
- Gout pathophysiology involves crystal deposition and inflammation.
- Traditional treatments focus on acute attack relief and urate lowering.
- New agents offer improved efficacy and safety profiles.
Conclusions:
- Effective management of gout requires addressing both acute symptoms and underlying hyperuricemia.
- Emerging therapies show promise for improved patient outcomes.
- Further research into novel targets is crucial for advancing gout pharmacotherapy.
Abstract:
The incidence of gout and the clinical manifestation of hyperuricemia continue to rise. In addition to painful acute attacks, chronic gout can lead to the development of crystal arthropathy, tophi, and renal lithiasis, coincidental with declines in quality of life. As a greater appreciation for the associations between hyperuricemia, gout, and certain comorbidities, such as renal impairment and cardiovascular diseases, grows, so does the search for new therapeutic options to both alleviate the painful symptoms of acute gout attacks and reduce the underlying hyperuricemia. This manuscript reviews the pathophysiology of hyperuricemia and gout, and associated comorbidities, and then discusses traditional therapeutic options, newly available agents, and future targets for pharmacologic management.
Related Concept Videos
Urinary Tract Calculi III: Medical Management
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Nephrotic Syndrome II : Assessment and Medical Management
Peripheral Artery Disease III: Interprofessional Care